Taylor RP - Search Results

1

B cell complement receptor 2 transfer reaction.

Lindorfer MA, Jinivizian HB, Foley PL, Kennedy AD, Solga MD, Taylor RP. Lindorfer MA, et al. Among authors: taylor rp. J Immunol. 2003 Apr 1;170(7):3671-8. doi: 10.4049/jimmunol.170.7.3671. J Immunol. 2003. PMID: 12646632

2

Concerted clearance of immune complexes bound to the human erythrocyte complement receptor: development of a heterologous mouse model.

Henderson AL, Lindorfer MA, Kennedy AD, Foley PL, Taylor RP. Henderson AL, et al. Among authors: taylor rp. J Immunol Methods. 2002 Dec 15;270(2):183-97. doi: 10.1016/s0022-1759(02)00296-x. J Immunol Methods. 2002. PMID: 12379324

3

An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20+ cells by rituximab.

Kennedy AD, Solga MD, Schuman TA, Chi AW, Lindorfer MA, Sutherland WM, Foley PL, Taylor RP. Kennedy AD, et al. Among authors: taylor rp. Blood. 2003 Feb 1;101(3):1071-9. doi: 10.1182/blood-2002-03-0876. Epub 2002 Sep 5. Blood. 2003. PMID: 12393727 Free article.

4

Rituximab infusion promotes rapid complement depletion and acute CD20 loss in chronic lymphocytic leukemia.

Kennedy AD, Beum PV, Solga MD, DiLillo DJ, Lindorfer MA, Hess CE, Densmore JJ, Williams ME, Taylor RP. Kennedy AD, et al. Among authors: taylor rp. J Immunol. 2004 Mar 1;172(5):3280-8. doi: 10.4049/jimmunol.172.5.3280. J Immunol. 2004. PMID: 14978136

5

Analyses of the in vivo trafficking of stoichiometric doses of an anti-complement receptor 1/2 monoclonal antibody infused intravenously in mice.

Whipple EC, Shanahan RS, Ditto AH, Taylor RP, Lindorfer MA. Whipple EC, et al. Among authors: taylor rp. J Immunol. 2004 Aug 15;173(4):2297-306. doi: 10.4049/jimmunol.173.4.2297. J Immunol. 2004. PMID: 15294942

6

Selective and efficient inhibition of the alternative pathway of complement by a mAb that recognizes C3b/iC3b.

DiLillo DJ, Pawluczkowycz AW, Peng W, Kennedy AD, Beum PV, Lindorfer MA, Taylor RP. DiLillo DJ, et al. Among authors: taylor rp. Mol Immunol. 2006 Mar;43(7):1010-9. doi: 10.1016/j.molimm.2005.05.003. Epub 2005 Jun 14. Mol Immunol. 2006. PMID: 15961157

7

The shaving reaction: rituximab/CD20 complexes are removed from mantle cell lymphoma and chronic lymphocytic leukemia cells by THP-1 monocytes.

Beum PV, Kennedy AD, Williams ME, Lindorfer MA, Taylor RP. Beum PV, et al. Among authors: taylor rp. J Immunol. 2006 Feb 15;176(4):2600-9. doi: 10.4049/jimmunol.176.4.2600. J Immunol. 2006. PMID: 16456022

8

Low doses of antigen coupled to anti-CR2 mAbs induce rapid and enduring IgG immune responses in mice and in cynomolgus monkeys.

Whipple EC, Ditto AH, Shanahan RS, Gatesman JJ, Little SF, Taylor RP, Lindorfer MA. Whipple EC, et al. Among authors: taylor rp. Mol Immunol. 2007 Jan;44(4):377-88. doi: 10.1016/j.molimm.2006.02.032. Epub 2006 May 2. Mol Immunol. 2007. PMID: 16631928

9

Thrice-weekly low-dose rituximab decreases CD20 loss via shaving and promotes enhanced targeting in chronic lymphocytic leukemia.

Williams ME, Densmore JJ, Pawluczkowycz AW, Beum PV, Kennedy AD, Lindorfer MA, Hamil SH, Eggleton JC, Taylor RP. Williams ME, et al. Among authors: taylor rp. J Immunol. 2006 Nov 15;177(10):7435-43. doi: 10.4049/jimmunol.177.10.7435. J Immunol. 2006. PMID: 17082663

10

Rituximab-CD20 complexes are shaved from Z138 mantle cell lymphoma cells in intravenous and subcutaneous SCID mouse models.

Li Y, Williams ME, Cousar JB, Pawluczkowycz AW, Lindorfer MA, Taylor RP. Li Y, et al. Among authors: taylor rp. J Immunol. 2007 Sep 15;179(6):4263-71. doi: 10.4049/jimmunol.179.6.4263. J Immunol. 2007. PMID: 17785867

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

309 results

Search Page

Filters